Pharmacological Association Recovery on MIMIC-IV
0.119Effect SizeFlatASCEND
Evaluation Results
| Method | Links | |||
|---|---|---|---|---|
| FlatASCENDComparison=Steroid → glucose, Type=Surrogate2026.04 | 0.119 | 0.001 | — | |
| FlatASCENDComparison=Insulin → glucose, Type=Surrogate2026.04 | 0.104 | 0.001 | — | |
| FlatASCENDComparison=Vasopressor → mortality, Type=Mortality2026.04 | 0.069 | 0.001 | — | |
| FlatASCENDComparison=Furosemide vs spiro → K, Type=Surrogate2026.04 | 0.061 | 0.001 | — | |
| FlatASCENDComparison=Warfarin → INR, Type=Surrogate2026.04 | 0.052 | 0.001 | — | |
| FlatASCENDComparison=Diuretic → K, Type=Surrogate2026.04 | 0.04 | 0.001 | — | |
| FlatASCENDComparison=Steroid sepsis → mortality, Type=Mortality2026.04 | 0.014 | 0.001 | — | |
| FlatASCENDComparison=Statin → glucose (null control), Type=Surrogate2026.04 | 0.012 | 0.002 | — | |
| FlatASCENDComparison=Anticoagulant → INR, Type=Surrogate2026.04 | 0.011 | 0.2 | — | |
| FlatASCENDComparison=Statin sepsis → mortality, Type=Mortality2026.04 | 0.004 | 0.0001 | — |